Delivery Order SPE2DB20D3103-SPE2DB23FN9X5
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical supplier, to provide EXJADE 125 MG TABLET 30S for $6,761.12. This order is associated with Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies for the Department...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Exjade 500 mg tablets in quantities of 30 units. This firm fixed price delivery order, valued at $16,027.08, is scheduled for completion by November 12, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's competitive...
- This is a delivery order federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EXJADE 500 MG TABLET 30S, with a firm fixed price and a ceiling value of $4,006.76. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EXJADE 500 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $16,027.08 and a period of performance through July 16, 2025. The contract is a firm fixed-price delivery order, which is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
- This federal contract award is for the delivery of EXJADE 250 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corp's Corporate Office division. The contract has a ceiling value of $3,418.22 and an ultimate completion date of April 1, 2024. Amerisourcebergen Drug Corp, a subsidiary of the larger Cencora, Inc. organization, is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of EXJADE 250 MG TABLET 30S. The contract has a potential value of $3,418.22 and a completion date of January 25, 2024. The contract supports the provision of pharmaceuticals and medical supplies to military treatment programs and facilities. No set-aside designation was used for this award....
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $28,728.06, is for the supply of JADENU 360 MG TABLET 30S, a specialty pharmaceutical product. The award has an ultimate completion date of October 16, 2024 and was made on October 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,625.87 fixed-price delivery order is for the supply of JADENU 360 MG TABLET 30S, a pharmaceutical product, with a performance period through March 26, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,380.66 firm fixed-price delivery order, designated as SPE2DX15D1053|SPE2DX25F6NBW, is for the supply of the medication Jadenu 360 mg tablet. The contract has an ultimate completion date of May 6, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,467.36 firm fixed-price delivery order is for the supply of JADENU 360 MG TABLET 30S, a medication, with a period of performance through May 20, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FN9X5Delivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,535.42 contract is for the delivery of Exjade 125 mg tablets and has an ultimate completion date of August 3, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating it was awarded through full and open competition. This delivery order is part of the broader DLA contracting efforts to procure essential pharmaceutical and medical commodities for military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 7/13/23 |